OHSU innovators
Tell us about a new idea or technology and learn how OHSU could help protect the intellectual property.
Startup support
Interested in forming a new company around your idea? Learn about how OHSU can help with startup company formation.
Collaborations
Learn more about existing OHSU partnerships and opportunities to work with OHSU community members.
Licensing opportunities
Visit the OHSU Technology Portal to search for existing licensing opportunities and review technology summaries.
Agreements
Learn more about commercialization and intellectual property agreements.
Entrepreneurial education
Learn more about OHSU curriculum and programs offered to provide entrepreneurial training to OHSU members.
OHSU Innovates 2025 Impact Report
Delve into the OHSU Innovates 2025 Impact Report to discover exciting advancements in healthcare, successful startups and innovative collaborations across the university. These initiatives reflect how OHSU is strengthening Oregon’s innovation community by supporting new clinical ventures, empowering innovators, recognizing leaders in medical innovation, advancing women’s health and highlighting emerging technologies.
Learn more about OHSU Innovates
OHSU Innovates is proud to support researchers and clinicians at OHSU who are striving to turn scientific ideas into real world solutions.
Hear from a few of these OHSU members and learn what motivates them and how OHSU fosters innovation, collaboration and entrepreneurship.
Subscribe to the OHSU Innovates newsletter for the latest news, programs and events.
Featured News
OHSU Startup Advances Potential Bipolar Depression Treatment
Building on an FDA Fast Track designation announced in May, OHSU startup company Autobahn Therapeutics reported positive topline Phase 2 results for elunetirom in June. The investigational treatment for bipolar depression met its primary and key secondary endpoints in the AMPLIFY-BD trial, providing the first clinical evidence for a CNS-targeted thyroid hormone receptor agonist approach. The milestone highlights the potential for new treatment options for people living with bipolar depression and reflects the impact of OHSU research translated into real-world innovation. Elunetirom is based on technology developed in the lab of Thomas Scanlan, Ph.D., professor of chemical physiology and biochemistry at the OHSU School of Medicine and co-founder and scientific adviser to Autobahn Therapeutics. OHSU licensed the technology to Autobahn in 2018 for further development.
Read more in Autobahn Therapeutics' announcements on the Phase 2 AMPLIFY-BD results and FDA Fast Track Designation.
Featured Event
AI and Your Ideas: What Innovators Need to Know
Artificial intelligence is transforming how organizations conduct research, develop new technologies and bring innovations to market. As AI becomes an increasingly important tool for researchers, entrepreneurs and innovators, it is creating new opportunities as well as new questions around ownership, confidentiality, intellectual property and legal risk.
Join attorneys Xavier Clark and Brittani Gambrell of Schwabe for a discussion on the legal and intellectual property considerations surrounding AI. The conversation will explore how organizations are incorporating AI into their innovation strategies, how AI may impact ownership of ideas and creative works, and what innovators should know about confidentiality, intellectual property rights and emerging legal developments.
When: Tuesday, Sept. 29, noon–1 p.m. PT
Where: Virtual
Who: Open to all
Cost: Free
Featured funding opportunity
Biomedical Innovation Program (BIP) Device, Diagnostic & Software
The Biomedical Innovation Program (BIP), a collaboration between OCTRI and OHSU Innovates, is accepting applications for its Device, Diagnostic & Software track. The program supports the development and commercialization of innovative technologies that improve healthcare delivery, with competitive awards of up to $40,000. Awardees also receive project management and commercialization mentorship to help advance promising technologies toward clinical and commercial impact.
Letters of intent are due Sept. 15, 2026.
See the Request for Applications (RFA) for details and application instructions.
OHSU Innovates collaborative network
Innovate Collaborate Oregon
OHSU Innovates is a proud partner of Innovate Collaborate Oregon (ICOregon), a collaborative network of Oregon institutions, which aims to further support and encourage the growth of innovation and entrepreneurship across the state. By bringing together resources across multiple institutions ICOregon aims to promote innovative discoveries, establish successful collaborations, form new companies, and increase economic development in Oregon.
Support OHSU Innovates
Become a sponsor
Learn more about how your organization can support innovation and entrepreneurship at OHSU and across the region.
Support innovation at OHSU
Help OHSU drive regional economic impact through entrepreneurship.
Learn more about the IDEA fund.
Gold Sponsor
Gold Sponsor
Silver Sponsor
Bronze Sponsor
